日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Discovery of Niclosamide Analogs with Potent Mitochondrial Uncoupling Activity and Reduced Mitochondrial Inhibition-Associated Toxicity

发现具有强效线粒体解偶联活性和降低线粒体抑制相关毒性的尼克酰胺类似物

期刊:ACS Medicinal Chemistry Letters
影响因子:4
doi:10.1021/acsmedchemlett.5c00439
Jiang, Haowen; Macorano, Alessio; Xing, Enming; Jedoui, Mohamed; Mohammed, Shabber; Lee, Vanessa; Cheng, Jeffrey; McDonough, Lain; Cheng, Xiaolin; Ye, Jiangbin; Li, Pui Kai
线粒体
毒理研究
发表日期：2026
文献求助 收藏

Valine-Niclosamide for Treatment of Androgen Receptor Splice Variant-Positive Hepatocellular Carcinoma.

缬氨酸-尼克酰胺用于治疗雄激素受体剪接变异体阳性肝细胞癌

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17152535
Hoelzen Emma J, Radomska Hanna S, Kulp Samuel K, Adeluola Adeoluwa A, Granchie Lauren A, Cheng Jeffrey, Dauki Anees M, Campbell Moray J, Mohammed Shabber, Xing Enming, Hai Min, Fukuda Mayu, Cheng Xiaolin, Phelps Mitch A, Li Pui-Kai, Coss Christopher C
细胞生物学
发表日期：2025
文献求助 收藏

Steroid Sulfatase Regulates Metabolic Reprogramming in Advanced Prostate Cancer.

类固醇硫酸酯酶调节晚期前列腺癌的代谢重编程

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17121959
Sharifi Masuda, Armstrong Cameron M, Ning Shu, Leslie Amy R, Schaaf Zachary A, Maine James P, Lou Wei, Li Pui-Kai, Xu Hongyu, Liu Chengfei, Gao Allen C
代谢
前列腺癌
代谢重编程
发表日期：2025
文献求助 收藏

Netupitant Exhibits Potent Activity on Mycobacterium tuberculosis Persisters

奈妥匹坦对结核分枝杆菌持续菌表现出强效活性

期刊:ACS Infectious Diseases
影响因子:3.8
doi:10.1021/acsinfecdis.5c00298
Eldesouky, Hassan E; Jones, Richard M; Mohammed, Shabber; Xing, Enming; Li, Pui-Kai; Sherman, David R
发表日期：2025
文献求助 收藏

The pH gradient contributes to persistence in Mycobacterium tuberculosis

pH梯度有助于结核分枝杆菌的持续存在

期刊:
影响因子:
doi:10.21203/rs.3.rs-7466214/v1
Sherman, David; Eldesouky, Hassan; Adams, Kristin; Brache, Justin; Aguila, Laarni; Garcia, Mariana; Xing, Enming; Li, Pui-Kai
发表日期：2025
文献求助 收藏

LX1 Dual Targets AR Variants and AKR1C3 in Advanced Prostate Cancer Therapy.

LX1 双靶点 AR 变异体和 AKR1C3 在晚期前列腺癌治疗中的应用

期刊:Cancer Research
影响因子:16.6
doi:10.1158/0008-5472.CAN-24-0440
Ning Shu, Armstrong Cameron M, Xing Enming, Leslie Amy R, Gao Richard Y, Sharifi Masuda, Schaaf Zachary A, Lou Wei, Han Xiangrui, Xu Desiree H, Yang Rui, Cheng Jeffrey, Mohammed Shabber, Mitsiades Nicholas, Liu Chengfei, Lombard Alan P, Wu Chun-Yi, Cheng Xiaolin, Li Pui-Kai, Gao Allen C
肿瘤
前列腺癌
肿瘤免疫
发表日期：2024
文献求助 收藏

Combinatorial targeting of glutamine metabolism and lysosomal-based lipid metabolism effectively suppresses glioblastoma

谷氨酰胺代谢和溶酶体脂质代谢的组合靶向有效抑制胶质母细胞瘤

期刊:Cell Reports Medicine
影响因子:11.7
doi:10.1016/j.xcrm.2024.101706
Yaogang Zhong, Feng Geng, Logan Mazik, Xinmin Yin, Aline Paixao Becker, Shabber Mohammed, Huali Su, Enming Xing, Yongjun Kou, Cheng-Yao Chiang, Yunzhou Fan, Yongchen Guo, Qiang Wang, Pui-Kai Li, Xiaokui Mo, Etienne Lefai, Liqing He, Xiaolin Cheng, Xiang Zhang, Arnab Chakravarti, Deliang Guo
代谢
胶质细胞
Human
SREBP-1
发表日期：2024
文献求助 收藏

Computational modeling studies reveal the origin of the binding preference of 3-(3,4-di hydroisoquinolin-2(1H)-ylsulfonyl)benzoic acids for AKR1C3 over its isoforms

计算模型研究揭示了 3-(3,4-二氢异喹啉-2(1H)-基磺酰基)苯甲酸对 AKR1C3 的结合偏好性高于其同工酶的起源

期刊:Protein Science
影响因子:5.2
doi:10.1002/pro.4499
Kong, Xiaotian; Xing, Enming; Wu, Sijin; Zhuang, Tony; Li, Pui-Kai; Li, Chunhua; Cheng, Xiaolin
发表日期：2022
文献求助 收藏

Constitutively Active Androgen Receptor in Hepatocellular Carcinoma

肝细胞癌中的组成性活性雄激素受体

期刊:International Journal of Molecular Sciences
影响因子:0.7
doi:10.3390/ijms232213768
Emma J Montgomery, Enming Xing, Moray J Campbell, Pui-Kai Li, James S Blachly, Allan Tsung, Christopher C Coss
肿瘤
肝癌
其它细胞
发表日期：2022
文献求助 收藏

ARVib suppresses growth of advanced prostate cancer via inhibition of androgen receptor signaling

ARVib 通过抑制雄激素受体信号来抑制晚期前列腺癌的生长

期刊:Oncogene
影响因子:6.9
doi:10.1038/s41388-021-01914-2
Chengfei Liu, Cameron M Armstrong, Shu Ning, Joy C Yang, Wei Lou, Alan P Lombard, Jinge Zhao, Chun-Yi Wu, Aiming Yu, Christopher P Evans, Clifford G Tepper, Pui-Kai Li, Allen C Gao
肿瘤
前列腺癌
发表日期：2021
文献求助 收藏